Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study
- Resource Type
- Article
- Source
- In
Clinica e Investigacion en Arteriosclerosis November-December 2023 35(6):263-271 - Subject
- Language
- ISSN
- 0214-9168